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Acute lymphoblastic leukemia (ALL) is a hematological cancer associated with precursor B-cells and is the
most common cancer diagnosed in children under the age of 15. Our complete understanding of all
mechanisms responsible for ALL induction is inadequate. DNA methylation is an epigenetic modification
and is accountable for regulating gene expression and plays a significant role in hematopoiesis. In addition
to genomic rearrangements and hyperdiploidy, other mechanisms like alteration of DNA methylation may
be involved in ALL pathogenesis. Therefore, the identification of altered DNA methylation on key regulatory
regions of the genome is critical to gaining a better understanding of ALL pathogenesis. This dissertation
identified the dynamic establishment of DNA methylation during normal B-cell development, and alterations
of DNA methylation in the pathogenesis of ALL. First, a protocol to isolate the subsets of precursor B-cells
from human umbilical cord blood (HCB) was developed. Using this protocol, we were able to isolate
sufficient numbers of pro-B, pre-BI, pre-BII and naïve B-cells from a single HCB unit. This method can be
adapted for any type of cell present in HCB at any stage of differentiation. Next, genome-wide DNA
methylation profiles using the methylated CpG island recovery assay followed by next generation
sequencing (MIRA-seq) were generated for each of the four subsets of precursor B-cells. We report for the
first time that gaining of DNA methylation in certain regions of genome were associated with the transition
of pro-B to pre-BI cells. Differentially methylated regions were identified and the majority of the regions were
present within intronic and intergenic regions that harbor putative regulatory elements. The development of
methylation profiles in normal precursor B-cells will aid in revealing the role of altered DNA methylation in
the pathogenesis of precursor B-cell related disorders including ALL. In order to identify epigenetic
alterations in ALL, we next determined the differentially methylated regions (DMRs) between ALL and
healthy precursor B-cells. Further, whole genome genes expression analysis was performed to determine
the regulatory potential of the DMRs. Our studies identified ALL specific epigenetically deregulated genes,
novel putative enhancers, and biological pathways that showed concurrent DNA methylation and changes
in gene expression during malignant transformation. These altered epigenetic marks could be used as
prospective biomarkers for ALL and/or as potential targets to reset the altered DNA methylation in order to
modify gene expression which may enhance the present treatment protocol for ALL and eventually improve
patient outcome.
